Armata Pharmaceuticals (ARMP) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-0.45 and quarterly revenue of $504.00K.
In the most recent quarter (Q1), Armata Pharmaceuticals reported EPS of $-3.16, missing estimates of $-0.39 by 7.10%. Revenue came in at $789.00K, exceeding the estimate of $0 by 0.00%.
Armata Pharmaceuticals has missed EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Armata Pharmaceuticals has averaged an EPS surprise of 6.27% and a revenue surprise of 0.26%.
Analyze the earnings history of Armata Pharmaceuticals using advanced sorting and filters.
The chart below shows Armata Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Armata Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
Armata Pharmaceuticals (ARMP) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 13, 2026 for Q1.
The Actual EPS was $-3.16, which missed the estimate of $-0.39.
The Actual Revenue was $789.00K, which beat the estimate of $0.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-13 | $-3.16 | $-0.39 | -710.3 % |
| Q4 | 2026-03-25 | $-3.43 | $-0.19 | -1705.3 % |
| Q3 | 2025-11-12 | $-0.74 | $-0.42 | -76.2 % |
| Q2 | 2025-08-12 | $-0.45 | $-0.39 | -15.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-25 | $1.09M | $1.04M | 4.73 % |
| Q3 | 2025-11-12 | $1.16M | $1.38M | -16.0 % |
| Q2 | 2025-08-12 | $2.17M | $1.38M | 57.2 % |
| Q1 | 2025-05-14 | $491.00K | $1.38M | -64.4 % |